The present invention provides a novel gene-therapeutic agent for neurodegenerative diseases. The present invention allows Aß variants to be secreted out of cells and continuously supplies tau inhibitor peptides in the cells to allow wt Aß polymerization and wt tau polymerization to be slowed or inhibited and cytoto...